UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison between YM099 and Captopril in Rats with Renal Mass Reduction-Induced Progressive Renal Disease

Biological and Pharmaceutical Bulletin, 2005, Vol.28(2), pp.367-369

2005

Volltextzugriff (PDF)

A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity

The Journal of pharmacology and experimental therapeutics, 2000-10, Vol.295 (1), p.255

2000

Volltextzugriff (PDF)

Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor

The Journal of pharmacology and experimental therapeutics, 2001-09, Vol.298 (3), p.1142

2001

Volltextzugriff (PDF)

Comparison between YM099 and Captopril in Rats with Renal Mass Reduction-Induced Progressive Renal Disease

Biological & Pharmaceutical Bulletin, 2005, Vol.28 (2), p.367-369

2005

Volltextzugriff (PDF)

Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets

The Journal of pharmacology and experimental therapeutics, 2000-12, Vol.295 (3), p.1149

2000

Volltextzugriff (PDF)

Synthetic Studies on Selective Type 4 Phosphodiesterase (PDE 4) Inhibitors. 1. Structure–Activity Relationships and Pharmacological Evaluation of 1,8-Naphthyridin-2(1H)-one Derivatives

Chemical and Pharmaceutical Bulletin, 2002, Vol.50(8), pp.1050-1059

2002

Volltextzugriff (PDF)

Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats

European journal of pharmacology, 2003-02, Vol.461 (2), p.191-195

2003

Volltextzugriff (PDF)

Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats

European journal of pharmacology, 2005-03, Vol.510 (1), p.121-126

2005

Volltextzugriff (PDF)

Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray Crystallography

Journal of medicinal chemistry, 2001-02, Vol.44 (4), p.540-547

2001

Volltextzugriff (PDF)

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

Pharmacological research, 2002-11, Vol.46 (5), p.375-381

YATSU, T

2002

Volltextzugriff (PDF)

Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction

European journal of pharmacology, 2002-08, Vol.450 (2), p.169-177

2002

Volltextzugriff (PDF)

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V 1a AND V 2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

Pharmacological research, 2002-11, Vol.46 (5), p.375-381

2002

Volltextzugriff (PDF)

Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist

European journal of pharmacology, 2002-06, Vol.446 (1-3), p.129-138

2002

Volltextzugriff (PDF)

Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs

The Journal of pharmacology and experimental therapeutics, 2001-04, Vol.297 (1), p.165

2001

Volltextzugriff (PDF)

Pharmacological characterization of YM471, a novel potent vasopressin V 1A and V 2 receptor antagonist

European journal of pharmacology, 2002-06, Vol.446 (1), p.129-138

2002

Volltextzugriff (PDF)

Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs

Pharmacological research, 2002-11, Vol.46 (5), p.375-381

2002

Volltextzugriff (PDF)

Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist

European journal of pharmacology, 2002-06, Vol.446 (1-3), p.129-138

2002

Volltextzugriff (PDF)

Effect of OKY-046 and ONO-3708 on Liver Injury in Mice

Japanese Journal of Pharmacology, 1989-01, Vol.51 (2), p.191-198

1989

Volltextzugriff (PDF)

Effect of OKY-046 and ONO-3708 on Liver Injury in Mice

The Japanese Journal of Pharmacology, 1989, Vol.51(2), pp.191-197

1989

Volltextzugriff (PDF)

The role of thromboxane A2 in experimental liver injury in mice

Enshō, 1989, Vol.9 (3), p.201-204

1989

Volltextzugriff (PDF)

Role of peptide-leukotrienes in liver injury in mice

Inflammation, 1989-12, Vol.13 (6), p.673-680

1989

Volltextzugriff (PDF)

The Effect of Gomisin A on Immunologic Liver Injury in Mice

Planta medica, 1989-02, Vol.55 (1), p.13-17

1989

Volltextzugriff (PDF)

Synthetic Studies on Selective Type 4 Phosphodiesterase (PDE 4) Inhibitors. Part 1. Structure-Activity Relationships and Pharmacological Evaluation of 1,8-Naphthyridin-2(1H)-one Derivatives

ChemInform, 2003-01, Vol.34 (2), p.no-no

2003

Volltextzugriff (PDF)

Renal effects of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs

Japanese journal of pharmacology, 1991, Vol.55, p.344

1991

Volltextzugriff (PDF)

P-423 - Renal effects of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs

Japanese journal of pharmacology, 1991, Vol.55, p.344-344

1991

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(47)
Tagungsberichte
(4)

Sprache

Englisch
(50)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(18)
Animals
(17)
Male
(16)
Pharmacology & Pharmacy
(12)
Biological And Medical Sciences
(10)
Rats
(9)
Humans
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(7)
Dose-Response Relationship, Drug
(6)
Female
(6)
Mice
(5)
Adult
(4)
Phosphodiesterase Inhibitors - Pharmacology
(4)
Rats, Wistar
(4)
Technology
(4)
Antidiuretic Hormone Receptor Antagonists
(3)
Conivaptan
(3)
Ferrets
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison between YM099 and Captopril in Rats with Renal Mass Reduction-Induced Progressive Renal Disease

A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity

Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor

Comparison between YM099 and Captopril in Rats with Renal Mass Reduction-Induced Progressive Renal Disease

Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets

Synthetic Studies on Selective Type 4 Phosphodiesterase (PDE 4) Inhibitors. 1. Structure–Activity Relationships and Pharmacological Evaluation of 1,8-Naphthyridin-2(1H)-one Derivatives

Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats

Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats

Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray Crystallography

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V 1a AND V 2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist

Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs

Pharmacological characterization of YM471, a novel potent vasopressin V 1A and V 2 receptor antagonist

Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs

Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist

Effect of OKY-046 and ONO-3708 on Liver Injury in Mice

Effect of OKY-046 and ONO-3708 on Liver Injury in Mice

The role of thromboxane A2 in experimental liver injury in mice

Role of peptide-leukotrienes in liver injury in mice

The Effect of Gomisin A on Immunologic Liver Injury in Mice

Synthetic Studies on Selective Type 4 Phosphodiesterase (PDE 4) Inhibitors. Part 1. Structure-Activity Relationships and Pharmacological Evaluation of 1,8-Naphthyridin-2(1H)-one Derivatives

Renal effects of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs

P-423 - Renal effects of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs

Suchergebnisse filtern